Fund Description
The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in The Health Care Select Sector Index. In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Fund Snapshot Updated 05.23.2013
| Previous Close | $49.22 | Expense Ratio | 0.21% |
| YTD Return | 24.0% | Avg. 30-Day Volume | 9,698,673 |
| 1-Year Return | 37.2% | Market Cap | Loading... |
| Bid | $49.26 | Shares Outstanding | 145,365,000 |
| Ask | $49.27 | Dividends | $0.81 |
| Top 10 Holdings | |
|---|---|
| Johnson & Johnson (JNJ) | 12.91% |
| Pfizer Inc (PFE) | 11.08% |
| Merck & Co Inc New (MRK) | 7.58% |
| Gilead Sciences Inc (GILD) | 4.47% |
| Amgen Inc (AMGN) | 4.19% |
| Bristol Myers Squibb Co (BMY) | 4.10% |
| Abbvie Inc (ABBV) | 3.90% |
| Unitedhealth Group Inc (UNH) | 3.41% |
| Biogen Idec Inc (BIIB) | 2.98% |
| Lilly Eli & Co (LLY) | 2.89% |
| % of Total Holdings | 57.50% |
